The oligonucleotide synthesis market involves the manufacturing of short nucleic acid strands for use in various applications such as research, diagnostics, and therapeutics. Oligonucleotides consist of short DNA or RNA fragments which are made of nucleotide monomers linked by phosphodiester bonds. They are used in a wide range of applications including diagnostics, therapeutics, research by interacting with or mimicking natural nucleic acids. The growing prevalence of diseases such as cancer and infectious diseases is driving the demand for oligonucleotides as they are used in developing treatment options such as antisense oligonucleotides.

The Global Oligonucleotide Synthesis Market is estimated to be valued at US$ 4565 Bn in 2024 and is expected to exhibit a CAGR of 13% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the Oligonucleotide Synthesis Market Trend  are Forte Research Systems (India), ICON plc (Ireland), Merge healthcare incorporated (U.S.), Bio-Optronics (U.S.), DSG INC (U.S.), ArisGlobal (India), ERT Clinical Bioclinica (U.S.), Oracle Corporation (U.S.), Medidata Solutions (U.S.), DATATRAK International, Inc. (U.S.), and MedNet Solutions, Inc., (U.S.) among others. The rising global burden of chronic diseases has boosted the demand for oligonucleotides in diagnostic and therapeutic applications. Advances in sequencing technologies have enabled the development of personalized medicine approaches utilizing oligonucleotides.

Growing demand for personalized medicine around the world is expected to drive the demand for oligonucleotides in the coming years. Personalized medicines involve developing treatments tailored to an individual's genetic characteristics and require oligonucleotides for target identification. Furthermore, increasing R&D investments in pharmaceutical and biotechnology companies is also leading to higher oligonucleotide adoption.

Adoption of automation technologies and synthetic process improvements by leading oligonucleotide manufacturers has enhanced process efficiencies. Advanced oligonucleotide technologies such as antisense oligonucleotides, aptamers, and small interfering RNA (siRNA) have augmented their clinical applications.

Market Trends

Large Scale Production - Companies are focusing on expanding their production scale to cater to the growing demand. Improvements in DNA/RNA synthesis capabilities has enabled large scale, cost-effective production.

Customized Services - Oligonucleotide manufacturers have started offering customized services such as chemical modifications and engineering to address the needs of specific end-use applications such as therapeutics and diagnostics.

Market Opportunities

Gene Therapy - Oligonucleotides play a key role in gene therapy procedures by facilitating gene silencing or activation. The growth of commercial gene therapies is expected to drive oligonucleotide demand.

Direct to Consumer genetic testing - Direct to consumer genetic testing allows individuals to access their genomics data. It utilizes oligonucleotides extensively and its growing popularity offers significant opportunities.

Impact of COVID-19 on the Oligonucleotide Synthesis Market

The COVID-19 pandemic has significantly impacted the growth of the oligonucleotide synthesis market. The increasing research on COVID-19 therapeutics like vaccines and antivirals boosted the demand for oligonucleotides during the peak of the pandemic. Research activities focussed on identifying genomic sequences of SARS-CoV-2 virus and developing oligonucleotide-based diagnostics tests and therapeutics. Several oligonucleotide drug makers expedited their clinical trials during this period. However, supply chain disruptions and restrictions on non-essential laboratory research caused short-term declined in oligonucleotide synthesis during the initial lockdown phases. With resumption of operations and prioritization of COVID-19 research, oligonucleotide synthesis demand bounced back and continued to grow through 2021.

Going forward, oligonucleotide synthesis is expected to witness sustained growth as the pandemic has elevated the focus on precision medicine and nucleic acid therapeutics. Pharmaceutical companies are developing oligonucleotide vaccines and antivirals to address future coronavirus outbreaks. The insights gained on genome sequencing and diagnostics during COVID-19 will help expedite oligonucleotide drug development for other diseases as well. However, geopolitical issues, international trade barriers and uncertain economic recovery post-pandemic may pose challenges. Strategic partnerships, investments in capacity expansion and automation, along with government funding support can help the market maintain its strong growth momentum in the post-pandemic era.

In terms of geography, North America region accounts for the largest value share in the oligonucleotide synthesis market owing to presence of major pharmaceutical companies and research labs. Besides, strong funding and government support for genetic engineering and synthetic biology drives regional market growth. However, Asia Pacific region is witnessing the fastest growth and emerging as a new hotspot for oligonucleotide synthesis. Countries like India, China and South Korea are aggressively developing capabilities in genomics and nucleic acid therapeutics. Expanding biotech industries, low manufacturing costs and growing drug development outsourcing are propelling Asia Pacific market growth.

Europe holds the second largest value share in the oligonucleotide synthesis market. Several European countries offer favourable regulations and funding incentives for synthetic biology, precision medicine and oligonucleotide drug research. Presence of global pharmaceutical leaders and comprehensive national healthcare systems support regional market growth. However, macroeconomic challenges, regulatory complexities and pricing pressures may impact the oligonucleotide synthesis business in the long run.

Due to increasing research on COVID-19 therapeutics, North America and Asia Pacific are presently the most concentrated and fastest growing regions for the oligonucleotide synthesis market in terms of value respectively. The pandemic has elevated focus on genomic medicine globally and especially in Asia which will likely ensure continuation of these regional leadership positions. However, Europe will also remain a major market owing to wide pharmaceutical capabilities and pro-research government policies in the long run.

Get More Insights On Oligonucleotide Synthesis Market